pyrimidine has been researched along with azacitidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TY; Demers, A; Hatch, GM; Mamarbachi, M; Mayer, G; Poirier, S; Samami, S; Vance, DE | 1 |
| Carraway, H; Durkin, L; Grabowski, D; Gu, X; Hamilton, B; Hasipek, M; Hong, C; Hsi, ED; Jha, BK; Maciejewski, J; Patel, B; Radivoyevitch, T; Sakre, N; Saunthararajah, Y; Schuerger, C; Sobecks, R; Tohme, R; Tomlinson, B; Zidan, AM | 1 |
| Fukuda-Kurahashi, Y; Kamachi, K; Kimura, S; Kurahashi, Y; Ureshino, H; Watanabe, T; Yamamoto, Y; Yoshida-Sakai, N | 1 |
3 other study(ies) available for pyrimidine and azacitidine
| Article | Year |
|---|---|
The epigenetic drug 5-azacytidine interferes with cholesterol and lipid metabolism.
Topics: Animals; Azacitidine; Cell Line, Tumor; Cell Nucleus; Cholesterol; Cricetinae; DNA Methylation; Epigenesis, Genetic; Homeostasis; Humans; Liver; Male; Mice; Pyrimidines; Sterol Regulatory Element Binding Protein 2 | 2014 |
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Metabolic Networks and Pathways; Mice; Pyrimidines; Uridine Kinase | 2021 |
Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism.
Topics: Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Decitabine; Deoxycytidine Kinase; DNA Methylation; Drug Resistance, Neoplasm; Humans; Leukemia-Lymphoma, Adult T-Cell; Pyridines; Pyrimidines; Uridine Kinase | 2022 |